Kim Young-Kyun, Kim Jeong-Whun, Yoon In-Young, Rhee Chae Seo, Lee Chul Hee, Yun Pil-Young
Department of Oral and Maxillofacial Surgery, Section of Dentistry, Seoul National University Bundang Hospital, 300, Gumi-dong, Bundang-gu, 463-707, Seongnam-si, Gyeonggi-do, South Korea.
Sleep Breath. 2014 May;18(2):305-11. doi: 10.1007/s11325-013-0885-5. Epub 2013 Aug 9.
The purposes of this study were to evaluate clinical outcome of mandibular advancement device (MAD) for obstructive sleep apnea (OSA) patients and to estimate influencing factors on MAD effect.
From the patients who were diagnosed as OSA by polysomnography at Seoul National University Bundang Hospital from January 2007 to February 2009, the patients who chose MAD as initial treatment option were included. All the patients' data were collected by reviewing and analyzing medical record and radiograph retrospectively.
Eighty-six patients (76 males and 10 females; mean age of 51.5 ± 9.8 years) with OSA were included in this study. Total success rate of MAD treatment was 47.7% (41/86 patients). Among cephalometric parameters, lower facial height (35.61 ± 4.26 vs. 38.19 ± 4.89) showed significant difference between success group and non-success group. From the polysomnographic parameters, apnea index (19.79 ± 17.32 vs. 30.08 ± 23.28), average oxygen saturation (95.03 ± 1.42 vs. 94.32 ± 1.56), lowest oxygen saturation (81.44 ± 6.64 vs. 76.87 ± 7.98), oxygen saturation under 90% (4.47 ± 5.90 vs. 9.01 ± 9.29), and oxygen desaturation index (23.58 ± 17.46 vs. 37.16 ± 22.35) showed significant difference between groups.
From the results, it was proved that MAD was an effective treatment option for the OSA patients. Some cephalometric and polysomnographic parameters including posterior lower facial height, apnea index, average oxygen saturation, lowest oxygen saturation, oxygen saturation under 90 %, and oxygen desaturation index could be influencing factors on MAD effect.
本研究旨在评估下颌前移装置(MAD)治疗阻塞性睡眠呼吸暂停(OSA)患者的临床疗效,并评估影响MAD疗效的因素。
纳入2007年1月至2009年2月在首尔国立大学盆唐医院经多导睡眠图诊断为OSA且选择MAD作为初始治疗方案的患者。通过回顾性查阅和分析病历及X线片收集所有患者的数据。
本研究纳入了86例OSA患者(76例男性,10例女性;平均年龄51.5±9.8岁)。MAD治疗的总成功率为47.7%(41/86例患者)。在头影测量参数中,成功组和非成功组之间下颌面部高度(35.61±4.26 vs. 38.19±4.89)存在显著差异。在多导睡眠图参数方面,呼吸暂停指数(19.79±17.32 vs. 30.08±23.28)、平均血氧饱和度(95.03±1.42 vs. 94.32±1.56)、最低血氧饱和度(81.44±6.64 vs. 76.87±7.98)、血氧饱和度低于90%的情况(4.47±5.90 vs. 9.01±9.29)以及血氧饱和度下降指数(23.58±17.46 vs. 37.16±22.35)在两组之间存在显著差异。
结果表明,MAD是治疗OSA患者的有效治疗方案。一些头影测量和多导睡眠图参数,包括下颌后面部高度、呼吸暂停指数、平均血氧饱和度、最低血氧饱和度、血氧饱和度低于90%的情况以及血氧饱和度下降指数可能是影响MAD疗效的因素。